TITLE

U.S. drug maker's new Czech plant to make vaccine

AUTHOR(S)
Kirkland, Joel
PUB. DATE
March 2002
SOURCE
Prague Business Journal;3/18/2002, Vol. 7 Issue 11, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the production of flu vaccine by Baxter International Inc. in Prague, Czech Republic. Production of InfluJect, flu vaccine; Purchase of Sevac by Baxter; Advantage of the vaccine.
ACCESSION #
6396275

 

Related Articles

  • Baxter fighting bird flu.  // R&D Magazine;Feb2007, Vol. 49 Issue 2, p26 

    The article reports on a Memorandum of Understanding signed by medical manufacturer Baxter International with the Indonesian government to help fight the bird flu there. Baxter has been working with the World Health Organization in Great Britain, U.S., Japan and Australia to access newly...

  • Baxter Receives Marketing Authorization in European Union for VEPACEL Pre- Pandemic Influenza Vaccine.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article reports that the marketing authorization of pre-pandemic influenza vaccine VEPACEL of Baxter International Inc. has been granted by the European Commission (EC). It is mentioned that the vaccine has been made with the use of Vero cell technology in which natural influenza virus is...

  • Baxter's Cell Culture-Based Pandemic Flu Vaccine Receives EMEA Positive Opinion.  // BioPharm International;Feb2009, Vol. 22 Issue 2, p13 

    The article reports on the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) towards celvapan, the first cell culture-based H5N1 (avian flu) pandemic vaccine by Baxter International Inc. The CHMP has recommended market...

  • BAXTER GETS CONTRACT FROM U.K. NHS FOR H5N1 FLU VACCINE.  // Worldwide Biotech;Apr2006, Vol. 18 Issue 4, p8 

    Reports on the contract from the National Health Service in Great Britain received by the European subsidiary of Baxter International Inc. to produce a stockpile of candidate H5N1 influenza vaccine based on an avian strain. Terms of the contract; Remarks from Joy Amundson, corporate vice...

  • Drug makers scramble to create swine flu vaccine. DeArment, Alaric // Drug Store News;5/25/2009, Vol. 31 Issue 6, p4 

    The article reports on the growth of drug companies developing vaccines for the treatment of H1N1 influenza in the U.S. It reveals that Baxter International Inc. plans to develop Celvapan with the strain of A/H1N1, meanwhile, biotechnology company Novavax Inc. will create vaccines that will...

  • IS VESTED INTEREST BEHIND SWINE FLU?  // Natural Health & Vegetarian Life;Spring2009, p17 

    A letter about Baxter International, a multinational pharmaceutical company which received contracts to produce and distribute swine flue vaccine, is presented. It notes that the firm's Austrian branch sent batches of human influenza vaccine to European countries and were found to be...

  • Vaccine Report.  // BioPharm International;Jan2011, Vol. 24 Issue 1, p10 

    The article offers updates related to vaccine development. A research agreement was signed by Tolerx Inc. and Cancer Vaccine Acceleration Fund (CVAF) to develop Tolerx's drug candidate TRX518 which is a monoclonal antibody. Baxter International Inc. and Takeda Pharmaceutical Co. Ltd. has signed...

  • Infectious Diseases News Round-Up.  // PharmaWatch: Monthly Review;Aug2009, Vol. 8 Issue 8, p21 

    The article offers world news briefs related to the pharmaceutical industry. Baxter International Inc. is developing an A/H1N1 vaccine using its Vero cell culture technology to respond the outbreak of H1N1 influenza. Novartis AG has received requests from over 30 governments for the delivery of...

  • Baxter in flu vaccine agreement with UK.  // Medical Device Daily;8/17/2007, Vol. 11 Issue 157, p8 

    The article reports on an advanced supply agreement signed by Baxter International's European subsidiary with the British Department of Health that involves an option to buy pandemic influenza vaccine. It is noted that the company will produce its pandemic vaccine in a serum-free, vero...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics